Vor Biopharma (VOR) EPS (Basic) (2020 - 2026)
Vor Biopharma (VOR) posted quarterly EPS (Basic) of -$0.73 for Q1 2026, up 86.0% year-over-year from -$0.39 in Q1 2025, and up 78.39% quarter-over-quarter from -$3.37 in Q4 2025.
Powered by 
Analysis
Vor Biopharma (VOR) EPS (Basic) (2020 - 2026) Analysis & Trends
Vor Biopharma (VOR) has reported EPS (Basic) for 7 consecutive years, with -$0.73 the latest figure, recorded in Q1 2026.
- In Q1 2026, EPS (Basic) rose 86.0% year-over-year to -$0.73; the TTM figure through Mar 2026 stood at -$56.98 (down 195.68% YoY), while the FY2025 annual figure was -$60.63, up 18.68% from the prior year.
- EPS (Basic) advanced to -$0.73 in Q1 2026 per VOR's latest filing, from -$3.37 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.73 in Q1 2026 and bottomed at -$251.24 in Q2 2025.
- Historically, EPS (Basic) has averaged -$29.43 across 5 years, with a median of -$9.06 in 2024.
- Annual changes were most pronounced in 2025 — EPS (Basic) tumbled 2981.93% — and 2026, when it jumped 86.0%.
- Vor Biopharma's EPS (Basic) stood at -$12.09 in 2022, then surged by 35.35% to -$7.82 in 2023, then fell by 20.65% to -$9.43 in 2024, then soared by 64.26% to -$3.37 in 2025, then soared by 78.39% to -$0.73 in 2026.
- Business Quant data shows VOR's EPS (Basic) at -$0.73 in Q1 2026, -$3.37 in Q4 2025, and -$121.63 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 7.70 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -3.06 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 2.12 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1.23 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 0.18 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.06 |
| 10 | Vor Biopharma | 1.36 Bn | 1.36 Bn | - | -0.80 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.80 |
| Mar 31, 2026 | -0.73 |
| Dec 31, 2025 | -3.36 |
| Sep 30, 2025 | -121.63 |
| Jun 30, 2025 | -251.24 |
| Mar 31, 2025 | -5.21 |
| Dec 31, 2024 | -8.94 |
| Sep 30, 2024 | -8.05 |
| Jun 30, 2024 | -8.15 |
| Mar 31, 2024 | -9.06 |
| Dec 31, 2023 | -7.82 |
| Sep 30, 2023 | -9.82 |
| Jun 30, 2023 | -8.94 |
| Mar 31, 2023 | -8.58 |
| Dec 31, 2022 | -12.09 |
| Sep 30, 2022 | -12.52 |
| Jun 30, 2022 | -11.57 |
| Mar 31, 2022 | -12.19 |
| Dec 31, 2021 | -10.92 |
| Sep 30, 2021 | -10.05 |